Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

vutrisiran (Amvuttra)

Source date not recordedAnalyse record ↗

RNAi drug to reduce TTR production made by Alnylam, approved for hATTR, but in trials for ATTR-CM with a paper already suggesting clear benefit.

Modality
subcutaneous injection
Availability (US)
by prescription (very expensive), but only for hATTR for now
Biomarkers
ATTR scan
Hallmark targeted
proteostasis / ATTR tx
Kind
age slowing
Other papers
ATTR-CM paper
Clinical trials
4 listed